United States
Thank you for contacting us; we’ll be in touch shortly.
The TraceLink Life Sciences Cloud: Talking to Companies in Their Own Format
The TraceLink network plays translator for more than 235,000 companies, seamlessly exchanging compliance data with customers, suppliers and trade…
A Make-or-Break Decision: Choosing the Right Serialization Technology for Revenue, Operational, and Brand Success
Understand the serialization challenge in the pharma supply chain and how relational vs. NoSQL databases fare in meeting it. Get the whitepaper now.
Serialization: Where to Begin
Understand the DSCSA serialization requirements, and how they can impact small pharma organizations.
Smarter CMO Onboarding: Speed Up Serialization with Network Efficiency
Learn how a network approach is the best way to boost the efficiencies of CMO onboarding with brand owner customers.
Hidden Costs of Serialization
Are you prepared to navigate the entire serialization iceberg? View a breakdown of all costs you will incur.
Operational Efficiency Matters: Why Knox Community Hospital Changed DSCSA Solutions
Not all DSCSA compliance solutions are created equally. That’s what Knox Community Hospital discovered the hard way, after struggling with “an…
Preparing for EU FMD & DSCSA: The Sharp Packaging Solution Perspective
Hear Sharp technical executives discuss the similarities and the critical differences between U.S. DSCSA and EU FMD.
Poll: 4 of 5 Phase 3s Are Preparing for Serialization Before FDA Approval
Polls show that 82% of clinical-stage virtual pharma companies, uncertain about the impact of serialization, are preparing for DSCSA compliance now.
To Aggregate or Not: 5 Deciding Factors
Here are 5 questions to ask yourself when creating a strategy for serial number aggregation that will set you up for long-term success.
Minimizing Time and Risk with an End-to-End Network
Watch this video to see why traditional point-to-point architecture is not a good fit for new track and trace serialization regulations.
Mutual Drug Discusses DSCSA Compliance Challenges
Hear Mutual Drug discuss their criteria for selecting a DSCSA solution partner plus compliance challenges.
Excellis Q&A: Why Phase 3 Manufacturers Shouldn’t Delay Serialization
See how Excellis Health Solutions avoids bottlenecks in serialization implementation, DSCSA challenges, and their philosophy behind phase 3 planning.